Albemarle Corp buy Argus
Start price
17.11.25
/
50%
€107.94
Target price
17.11.26
€120.61
Performance (%)
14.36%
Price
09:29
€123.44
Summary
This prediction is currently active. The prediction currently has a performance of 14.36%. This prediction currently runs until 17.11.26. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Albemarle Corp | -0.695% | -0.695% |
| iShares Core DAX® | 0.323% | 2.208% |
| iShares Nasdaq 100 | 0.145% | -0.987% |
| iShares Nikkei 225® | 0.091% | -1.421% |
| iShares S&P 500 | 0.371% | -0.469% |
Comments by Argus for this prediction
In the thread Albemarle Corp diskutieren
Albemarle (NYSE:ALB) had its price target raised by analysts at Argus from $120.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat